Patent Thickets Constrain US Biosimilars Market

Patent Thickets Constrain US Biosimilars Market

Patent Thickets Constrain US Biosimilars Market Alex Brill and Christy Robinson | BioProcess International Biosimilars represent a significant cost-savings opportunity in the United States because they can introduce competition for some of the most expensive and...